![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
12
PharmaCompass offers a list of Glibenclamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glibenclamide manufacturer or Glibenclamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glibenclamide manufacturer or Glibenclamide supplier.
PharmaCompass also assists you with knowing the Glibenclamide API Price utilized in the formulation of products. Glibenclamide API Price is not always fixed or binding as the Glibenclamide Price is obtained through a variety of data sources. The Glibenclamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glyburide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glyburide, including repackagers and relabelers. The FDA regulates Glyburide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glyburide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glyburide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glyburide supplier is an individual or a company that provides Glyburide active pharmaceutical ingredient (API) or Glyburide finished formulations upon request. The Glyburide suppliers may include Glyburide API manufacturers, exporters, distributors and traders.
click here to find a list of Glyburide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glyburide DMF (Drug Master File) is a document detailing the whole manufacturing process of Glyburide active pharmaceutical ingredient (API) in detail. Different forms of Glyburide DMFs exist exist since differing nations have different regulations, such as Glyburide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glyburide DMF submitted to regulatory agencies in the US is known as a USDMF. Glyburide USDMF includes data on Glyburide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glyburide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glyburide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Glyburide Drug Master File in Japan (Glyburide JDMF) empowers Glyburide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Glyburide JDMF during the approval evaluation for pharmaceutical products. At the time of Glyburide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Glyburide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glyburide Drug Master File in Korea (Glyburide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glyburide. The MFDS reviews the Glyburide KDMF as part of the drug registration process and uses the information provided in the Glyburide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glyburide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glyburide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glyburide suppliers with KDMF on PharmaCompass.
A Glyburide CEP of the European Pharmacopoeia monograph is often referred to as a Glyburide Certificate of Suitability (COS). The purpose of a Glyburide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glyburide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glyburide to their clients by showing that a Glyburide CEP has been issued for it. The manufacturer submits a Glyburide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glyburide CEP holder for the record. Additionally, the data presented in the Glyburide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glyburide DMF.
A Glyburide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glyburide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glyburide suppliers with CEP (COS) on PharmaCompass.
A Glyburide written confirmation (Glyburide WC) is an official document issued by a regulatory agency to a Glyburide manufacturer, verifying that the manufacturing facility of a Glyburide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glyburide APIs or Glyburide finished pharmaceutical products to another nation, regulatory agencies frequently require a Glyburide WC (written confirmation) as part of the regulatory process.
click here to find a list of Glyburide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glyburide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glyburide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glyburide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glyburide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glyburide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glyburide suppliers with NDC on PharmaCompass.
Glyburide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glyburide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glyburide GMP manufacturer or Glyburide GMP API supplier for your needs.
A Glyburide CoA (Certificate of Analysis) is a formal document that attests to Glyburide's compliance with Glyburide specifications and serves as a tool for batch-level quality control.
Glyburide CoA mostly includes findings from lab analyses of a specific batch. For each Glyburide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glyburide may be tested according to a variety of international standards, such as European Pharmacopoeia (Glyburide EP), Glyburide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glyburide USP).